Hannah S van Meurs
Overview
Explore the profile of Hannah S van Meurs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
270
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Groeneweg J, Roze J, Peters E, Sereno F, Brink A, Paijens S, et al.
Gynecol Oncol
. 2021 Jun;
162(2):413-420.
PMID: 34083028
Objective: Adult granulosa cell tumors (aGCTs) represent a rare, hormonally active subtype of ovarian cancer that has a tendency to relapse late and repeatedly. Current serum hormone markers are inaccurate...
2.
Roze J, van Meurs H, Monroe G, Veldhuis W, van Lonkhuijzen L, Bennink R, et al.
Oncotarget
. 2021 Apr;
12(7):665-673.
PMID: 33868587
Purpose: Adult granulosa cell tumors (AGCTs) of the ovary represent a rare malignancy in which timing and choice of treatment is a clinical challenge. This study investigates the value of...
3.
Pilsworth J, Cochrane D, Neilson S, Moussavi B, Lai D, Munzur A, et al.
J Pathol Clin Res
. 2021 Jan;
7(3):243-252.
PMID: 33428330
Adult-type granulosa cell tumors (aGCTs) account for 90% of malignant ovarian sex cord-stromal tumors and 2-5% of all ovarian cancers. These tumors are usually diagnosed at an early stage and...
4.
Beelen P, van den Brink M, Herman M, Geomini P, Dekker J, Duijnhoven R, et al.
Am J Obstet Gynecol
. 2020 Aug;
224(2):187.e1-187.e10.
PMID: 32795428
Background: Heavy menstrual bleeding affects the physical functioning and social well-being of many women. The levonorgestrel-releasing intrauterine system and endometrial ablation are 2 frequently applied treatments in women with heavy...
5.
van de Vrie R, van Meurs H, Rutten M, Naaktgeboren C, Opmeer B, Gaarenstroom K, et al.
Gynecol Oncol
. 2017 Jun;
146(3):449-456.
PMID: 28645428
Objective: To evaluate the cost-effectiveness of a diagnostic laparoscopy prior to primary cytoreductive surgery to prevent futile primary cytoreductive surgery (i.e. leaving >1cm residual disease) in patients suspected of advanced...
6.
Rutten M, van Meurs H, van de Vrie R, Gaarenstroom K, Naaktgeboren C, Van Gorp T, et al.
J Clin Oncol
. 2016 Dec;
35(6):613-621.
PMID: 28029317
Purpose To investigate whether initial diagnostic laparoscopy can prevent futile primary cytoreductive surgery (PCS) by identifying patients with advanced-stage ovarian cancer in whom > 1 cm of residual disease will...
7.
McConechy M, Farkkila A, Horlings H, Talhouk A, Unkila-Kallio L, van Meurs H, et al.
J Natl Cancer Inst
. 2016 Jun;
108(11).
PMID: 27297428
The histopathologic features of adult granulosa cell tumors (AGCTs) are relatively nonspecific, resulting in misdiagnosis of other cancers as AGCT, a problem that has not been well characterized. FOXL2 mutation...
8.
van Meurs H, van der Velden J, Buist M, van Driel W, Kenter G, van Lonkhuijzen L
Acta Obstet Gynecol Scand
. 2015 Aug;
94(11):1269-75.
PMID: 26230362
Introduction: The aim of this study was to retrospectively determine the objective response rate to hormone therapy (HT) for patients with a measurable adult granulosa cell tumor (GCT) of the...
9.
van Meurs H, Schuit E, Horlings H, van der Velden J, van Driel W, Mol B, et al.
Gynecol Oncol
. 2014 Jul;
134(3):498-504.
PMID: 24983647
Objective: Models to predict the probability of recurrence free survival exist for various types of malignancies, but a model for recurrence free survival in individuals with an adult granulosa cell...
10.
van Meurs H, van Lonkhuijzen L, Limpens J, van der Velden J, Buist M
Gynecol Oncol
. 2014 Apr;
134(1):196-205.
PMID: 24713548
Objective: This systematic review assessed the effectiveness of hormone therapy (HT) in patients with a granulosa cell tumor (GCT) of the ovary. Methods: Medline (OVID), EMBASE (OVID), the Cochrane Central...